Maurice Michel1,2, Alisha Wahl1,2, Malena Anders1,2, Saleh A Alqahtani3,4, Wolfgang M Kremer2, Peter R Galle2, Christian Labenz1,2, Daniel Grimm2, Martin Sprinzl2, Jörn M Schattenberg5,6. 1. Metabolic Liver Research Program, I. Department of Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. 2. I. Department of Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. 3. Liver Transplant Center, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. 4. Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD, USA. 5. Metabolic Liver Research Program, I. Department of Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. joern.schattenberg@unimedizin-mainz.de. 6. I. Department of Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. joern.schattenberg@unimedizin-mainz.de.
Abstract
PURPOSE: Liver-related comorbidities can impair the health-related quality of life (HRQL) in people living with human immunodeficiency virus (HIV) (PLWH). However, the role of hepatic steatosis and significant fibrosis in PLWH remains incompletely characterized. Therefore, the aim of this study was to explore the association of hepatic steatosis and significant fibrosis on the HRQL using the medical outcomes study HIV health survey (MOS-HIV) in PLWH. METHODS: A total of 222 PLWH were included in the final analysis of this cohort study. Metabolic comorbidities, socioeconomic factors, and HIV-related parameters were assessed. Hepatic steatosis and fibrosis were measured using vibration-controlled transient elastography (VCTE). The MOS-HIV survey, containing two summary scores (physical health summary (PHS) and mental health summary (MHS)) and ten domains, was used to assess the HRQL. Clinical predictors were identified using multivariable linear regression models. RESULTS: The majority of this cohort was male, and the median age was 52 years, with a high prevalence of hepatic steatosis (n = 81, 36.5%). Significant fibrosis was present in 7.7% (n = 17). The mean PHS and MHS scores were 52.7 ± 9.5 and 51.4 ± 10.5, respectively. The lowest scores were in the general health perception (GHP) and energy/fatigue (EF) domains. A high BMI and waist circumference were associated with a poor PHS score. Lower education, unemployment, arterial hypertension, and significant fibrosis remained independent predictors of an impaired HRQL. CONCLUSION: Metabolic comorbidities, significant fibrosis, and a lower socioeconomic status may negatively affect the HRQL in PLWH. Considering the negative impact of significant fibrosis on the outcome, counseling and preventive measures according to current guidelines are recommended in this subgroup of PLWH.
PURPOSE: Liver-related comorbidities can impair the health-related quality of life (HRQL) in people living with human immunodeficiency virus (HIV) (PLWH). However, the role of hepatic steatosis and significant fibrosis in PLWH remains incompletely characterized. Therefore, the aim of this study was to explore the association of hepatic steatosis and significant fibrosis on the HRQL using the medical outcomes study HIV health survey (MOS-HIV) in PLWH. METHODS: A total of 222 PLWH were included in the final analysis of this cohort study. Metabolic comorbidities, socioeconomic factors, and HIV-related parameters were assessed. Hepatic steatosis and fibrosis were measured using vibration-controlled transient elastography (VCTE). The MOS-HIV survey, containing two summary scores (physical health summary (PHS) and mental health summary (MHS)) and ten domains, was used to assess the HRQL. Clinical predictors were identified using multivariable linear regression models. RESULTS: The majority of this cohort was male, and the median age was 52 years, with a high prevalence of hepatic steatosis (n = 81, 36.5%). Significant fibrosis was present in 7.7% (n = 17). The mean PHS and MHS scores were 52.7 ± 9.5 and 51.4 ± 10.5, respectively. The lowest scores were in the general health perception (GHP) and energy/fatigue (EF) domains. A high BMI and waist circumference were associated with a poor PHS score. Lower education, unemployment, arterial hypertension, and significant fibrosis remained independent predictors of an impaired HRQL. CONCLUSION: Metabolic comorbidities, significant fibrosis, and a lower socioeconomic status may negatively affect the HRQL in PLWH. Considering the negative impact of significant fibrosis on the outcome, counseling and preventive measures according to current guidelines are recommended in this subgroup of PLWH.
Authors: Bernard Surial; Catrina Mugglin; Alexandra Calmy; Matthias Cavassini; Huldrych F Günthard; Marcel Stöckle; Enos Bernasconi; Patrick Schmid; Philip E Tarr; Hansjakob Furrer; Bruno Ledergerber; Gilles Wandeler; Andri Rauch Journal: Ann Intern Med Date: 2021-03-16 Impact factor: 25.391
Authors: Carmen H Logie; Ying Wang; Ashley Lacombe-Duncan; Anne C Wagner; Angela Kaida; Tracey Conway; Kath Webster; Alexandra de Pokomandy; Mona R Loutfy Journal: Prev Med Date: 2017-12-22 Impact factor: 4.018
Authors: Aslam H Anis; Bohdan Nosyk; Huiying Sun; Daphne P Guh; Nick Bansback; Xin Li; Paul G Barnett; Vilija Joyce; Kathleen M Swanson; Tassos C Kyriakides; Mark Holodniy; D William Cameron; Sheldon T Brown Journal: J Acquir Immune Defic Syndr Date: 2009-08-15 Impact factor: 3.731
Authors: Maurice Michel; Christian Labenz; Malena Anders; Alisha Wahl; Lisann Girolstein; Leonard Kaps; Wolfgang M Kremer; Yvonne Huber; Peter R Galle; Martin Sprinzl; Jörn M Schattenberg Journal: Hepatol Commun Date: 2022-04-12
Authors: Jeffrey V Lazarus; Kelly Safreed-Harmon; Adeeba Kamarulzaman; Jane Anderson; Ricardo Baptista Leite; Georg Behrens; Linda-Gail Bekker; Sanjay Bhagani; Darren Brown; Graham Brown; Susan Buchbinder; Carlos Caceres; Pedro E Cahn; Patrizia Carrieri; Georgina Caswell; Graham S Cooke; Antonella d'Arminio Monforte; Nikos Dedes; Julia Del Amo; Richard Elliott; Wafaa M El-Sadr; María José Fuster-Ruiz de Apodaca; Giovanni Guaraldi; Tim Hallett; Richard Harding; Margaret Hellard; Shabbar Jaffar; Meaghan Kall; Marina Klein; Sharon R Lewin; Ken Mayer; Jose A Pérez-Molina; Doreen Moraa; Denise Naniche; Denis Nash; Teymur Noori; Anton Pozniak; Reena Rajasuriar; Peter Reiss; Nesrine Rizk; Jürgen Rockstroh; Diana Romero; Caroline Sabin; David Serwadda; Laura Waters Journal: Nat Commun Date: 2021-07-16 Impact factor: 14.919